{"resourceType": "ArtifactAssessment", "id": "179698", "meta": {"versionId": "2", "lastUpdated": "2023-11-28T18:13:19.143Z", "profile": ["https://hl7.org/fhir/uv/ebm/StructureDefinition/adaptation"]}, "extension": [{"url": "http://hl7.org/fhir/StructureDefinition/artifact-status", "valueCode": "active"}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail": {"name": "Joanne Dehnbostel"}}, {"url": "http://hl7.org/fhir/StructureDefinition/artifact-url", "valueUri": "https://fevir.net/resources/ArtifactAssessment/179698"}], "identifier": [{"type": {"text": "FEvIR Object Identifier"}, "system": "https://fevir.net", "value": "179698", "assigner": {"display": "Computable Publishing LLC"}}], "title": "Joanne Dehnbostel's Adaptation Report of Recommendation: ADA Obesity Management Recommendation 8.16", "artifactReference": {"reference": "Composition/179466", "type": "Composition", "display": "Recommendation: ADA Obesity Management Recommendation 8.16"}, "content": [{"informationType": "container", "type": {"text": "adapted element"}, "classifier": [{"coding": [{"system": "https://fevir.net/resources/CodeSystem/112109", "code": "string-datatype", "display": "string Datatype"}]}], "path": ["overallSummary"], "component": [{"informationType": "comment", "summary": "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI \u226540 kg/m2 (BMI \u226537.5 kg/m2 in Asian Americans) and in adults with BMI 35.0\u201339.9 kg/m2 (32.5\u201337.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. A", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/112108", "code": "OriginalResourceContent", "display": "Original Resource Content"}]}}, {"informationType": "response", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/112108", "code": "RationaleForChange", "display": "Rationale for Change to Resource Content"}]}, "classifier": [{"coding": [{"system": "https://fevir.net/resources/CodeSystem/112109", "code": "suggested-change", "display": "Suggested change"}]}]}, {"informationType": "change-request", "summary": "8.16 Metabolic surgery should be a recommended option to treat type 2 diabetes in screened surgical candidates with BMI \u226540 kg/m2 (BMI \u226537.5 kg/m2 in Asian Americans) and in adults with BMI 35.0\u201339.9 kg/m2 (32.5\u201337.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. ", "type": {"coding": [{"system": "https://fevir.net/resources/CodeSystem/112108", "code": "SuggestedChange", "display": "Suggested Change to Resource Content"}]}}]}]}